Breast Cancer Research

official impact factor 5.79
Search for
Advanced search
Breast Cancer Research
Tools
Share this article
Open Access Highly Access Email this article to a friend

Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers -- role of estrogen receptor and HER2 reactivation

Yen-Chao Wang, Gladys Morrison, Ryan Gillihan, Jun Guo, Robin M Ward, Xiaoyong Fu, Maria F Botero, Nuala A Healy, Susan G Hilsenbeck, Gail L Phillips, Gary C Chamness, Mothaffar F Rimawi, C Kent Osborne and Rachel Schiff*

Breast Cancer Research 2011, 13:R121 doi:10.1186/bcr3067

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.